Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Oct 26.
Published in final edited form as: Epidemiology. 2014 Sep;25(5):682–688. doi: 10.1097/EDE.0000000000000126

Adult Air Pollution Exposure and Risk of Uterine Leiomyoma in the Nurses’ Health Study II

Shruthi Mahalingaiah a,*, Jaime E Hart b,c,*, Francine Laden b,c,d, Kathryn L Terry d,e,f, Renée Boynton-Jarrett g, Ann Aschengrau h, Stacey A Missmer b,d,f
PMCID: PMC4209294  NIHMSID: NIHMS634902  PMID: 24815304

Abstract

Background

Air pollution, particularly from vehicle exhaust, has been shown to influence hormonal activity. However, at present, it is unknown whether air pollution exposure is associated with the occurrence of uterine leiomyomata, a hormonally sensitive tumor of the uterus.

Methods

Proximity to major roadways and outdoor levels of PM less than 10 microns (PM10) or 2.5 microns (PM2.5) or between 10 and 2.5 microns (PM10–2.5) in diameter were determined for all residential addresses from September 1989 to May 2007 for 85,251 women aged 25–42 at enrollment in the Nurses’ Health Study II who were alive and responding to questionnaires, premenopausal with intact uteri, without diagnoses of cancer, or prevalent uterine leiomyomata. Incidence of ultrasound- or hysterectomy-confirmed uterine leiomyomata and covariates were reported on biennial questionnaires sent through May 2007. Multivariable time-varying Cox proportional hazard models were used to estimate the relation between distance to road or PM exposures and uterine leiomyomata risk.

Results

During 837,573 person-years of follow-up, there were 7,760 incident cases. Living close to a major road and exposures to PM10 or PM10–2.5 were not associated with an increased risk of uterine leiomyomata. However, each 10 µg/m3 increase in 2-year average, 4-year average, or cumulative average PM2.5 was associated with an adjusted hazard ratio (HR) of 1.08 (95% confidence interval (CI):1.00–1.17), 1.09 (95%CI:0.99–1.19) and 1.11 (95%CI:1.03–1.19), respectively.

Conclusions

Chronic exposure to PM2.5 may be associated with a modest increased risk of uterine leiomyomata.

Keywords: Air pollution, Distance to road, Uterine Fibroids, Leiomyoma, Prospective cohort


Uterine leiomyomata, known commonly as uterine fibroids, are present in a vast majority of women of reproductive age.1 Clinically significant disease is characterized by increase in uterine size, heavy menses potentially leading to anemia, pelvic pain, increased urinary frequency, and abdominal distension.2,3 Cumulative incidence of uterine leiomyomata is approximately70% in white women and 80% in African-American women by the age of 50 years.4 However incidence of clinically significant disease ranges between 15–30%.1 Treatment interventions include hormonal regulation of menses and surgical myomectomy in refractory cases.5 For women who have completed childbearing, hysterectomy is the gold standard treatment for uterine leiomyomata related symptoms.6

Many risk factors for uterine leiomyomata have been evaluated, including lifestyle, diet, anthropometric, genetic, and hormonal factors. Uterine leiomyomata are hormonally responsive clonal tumors of the uterus and are further categorized by their location in the uterus.7 A number of studies have evaluated exposure to environmental endocrine disruptors, such as diethylstilbestrol8,9 (mixed), phenols10 (null), dioxin11 (protective), and polychlorinated biphenyls (increased),12 but no clear patterns have emerged. A more recent study evaluated exposure to polycyclic aromatic hydrocarbons, another environmental estrogen-like compound, and odds of uterine leiomyomata expressing the aryl-hydrocarbon receptor13. Living closer to a polycyclic aromatic hydrocarbon producing company was associated with increased odds of uterine leiomyomata with aryl-hydrocarbon receptor over-expression.13 As air pollution is a major source of polycyclic aromatic hydrocarbons,14 and components of air pollution have been shown to have hormonal activity and to bind the aryl-hydrocarbon receptor in in vitro studies.1517 At present, it is unknown whether air pollution exposure is associated with the occurrence of uterine leiomyomata as no prior epidemiologic studies have assessed this relationship.

METHODS

Study Population

The Nurses’ Health Study II (NHSII) is a prospective cohort study of US female nurses. The cohort was initiated in 1989 when 116,686 female US registered nurses, 25 to 42 years old, completed a mailed questionnaire and provided informed consent. At baseline the nurses resided in fourteen states (California, Connecticut, Indiana, Iowa, Kentucky, Massachusetts, Michigan, Missouri, New York, North Carolina, Ohio, Pennsylvania, South Carolina and Texas), however, there is now at least one cohort member in all fifty states. Follow-up questionnaires, with response rates above 90%, are mailed every two years to update information on risk factors and the occurrence of major illnesses. These questionnaires also provide biennially updated information on residential addresses. Women were included in the current study if they were alive at the given questionnaire cycle, premenopausal, free of cancer (other than non-melanoma skin cancer), had no history of infertility, had intact uteri, and did not have a diagnosis of uterine leiomyomata prior to 1993. In addition, women were included only if they had at least one home address within the continental United States that could be geocoded to the street segment to allow the assignment of exposure (80–90% of the addresses for each biennial questionnaire cycle were successfully geocoded to the street segment level).

Assessment of Outcome

Initial assessment of uterine leiomyomata was performed in the 1993 NHSII questionnaire. Participants were asked if they had ever had a previous diagnosis of uterine leiomyomata, and if yes, to provide the date of diagnosis and method of confirmation (pelvic exam, ultrasound, or hysterectomy). Subsequent questionnaires asked each woman if she had been diagnosed with uterine leiomyomata before, during, or after the current two year study period. During the follow-up intervals, women were considered a case only if the diagnosis was confirmed via ultrasound or hysterectomy. Cases of uterine leiomyomata reported with only a pelvic exam as the method of confirmation were censored at the time of diagnosis, and were not considered cases. If these women later confirmed a diagnosis of uterine leiomyomata: by either ultrasound or hysterectomy, they were then counted as a case at the time of the original report. For all cases, the mid-point between the receipts of the questionnaire before and after diagnosis was assigned as the date of diagnosis. We used date of diagnosis to mark uterine leiomyomata incidence as opposed to the initiation of uterine leiomyomata development. Marshall et al. performed a validation study of 243 NHSII participants who self-reported a new diagnosis of uterine leiomyomata confirmed by ultrasound or hysterectomy. Self report was compared to medical record review and an average confirmation rate of 93% was found 18.

Exposure Assessment

We used distance to road at each biennial questionnaire address as a proxy for traffic exposure. Distance to road (in meters) for all available addresses from September 1989 to May 2007 was determined using Geographical Information System (GIS) software (ArcGIS 9.2, ESRI, Redlands, CA). Road segments from the ESRI StreetMap Pro 2007 files were selected by US Census Feature Class Code to include: A1 (primary roads, typically interstate highways, with limited access, division between the opposing directions of traffic, and defined exits), A2 (primary major, non-interstate highways and major roads without access restrictions), or A3 (smaller, secondary roads, usually with more than two lanes) road segments. Based on the distribution of distance to road in this population and exposure studies that have shown an exponential decay in exposures with increasing distance from a road, with levels equal to background concentrations at 150–200m, we categorized the exposure based on distance (0–50m, 51–199m, and 200+m).1923 To determine if larger roads (with more traffic) had a greater association with uterine leiomyomata risk, we also examined models restricted to distance to A1 and A2 roads only.

Predicted ambient exposure to PM10, PM10–2.5, and PM2.5 is available for each month since January 1988. These values are generated at each address in the residential address histories of each cohort member. These predictions are generated at the specific address level from nationwide expansions of previously validated spatiotemporal models.24,25 The models use monthly average PM10 and/or PM2.5 data from USEPA’s Air Quality System, a nationwide network of continuous and filter-based monitors, as well as monitoring data from various other sources. The models also incorporate a number of geographic information system (GIS) based predictors such as population density, land use, elevation, distance to road, PM point sources as well as meteorology. All PM data and GIS data were used in generalized additive statistical models 26 with smooth terms of space and time to create separate PM prediction surfaces for each month. By subtracting monthly PM10 and PM2.5 values, information was also available on PM10–2.5. As the etiologic window during which air pollution would influence uterine leiomyomata is unknown, we calculated three different chronic exposure measures: the average air pollution in the prior 2 calendar years, the average air pollution in the 4 prior calendar years, and a time-varying cumulative average exposure.

Additional Covariates

Information on potential confounders and effect modifiers is available every two years. Therefore, when appropriate, each woman was assigned updated covariate values from each questionnaire cycle. We examined possible confounding by numerous risk factors for uterine leiomyomata including: age (in months), race (Caucasian vs other), smoking status (current/former/never), body mass index (BMI, kg/m2), age at menarche (≤9, 10, 11, 12, 13, 14,15, 16, ≤17 years), parity (nulliparous/parous), diagnosis of infertility, age at first birth (≥26, 26–30, ≥31 years), age at last birth (≥26, 26–30, 31–35, ≥36 years), time since last birth (<1, 1–3, 4–5, 6–7, 8–9, 10–12, 13–15, ≥16 years), total months of exclusive breast feeding (none, 1–3, 4–6, 7–12, 13–18, 19–24, 25–36, ≥37 months) oral contraception use (never, current, former), antihypertensive medication use and blood pressure (using medication yes/no and diastolic blood pressure (<65, 65–74, 75–84, 85–89, ≥90 mmHg) overall diet quality as measured by the Alternative Healthy Eating Index,27 physical activity (MET-hrs/week), and individual-level socioeconomic status (marital status, household income, and if the nurse lived alone) and area- level socioeconomic status (Census tract level median home value and median family income). To adjust for potential differences in PM composition or diagnosis patterns by region of the country, we also considered adjustment for region (Northeast, Midwest, South, West). To determine potential confounding, each variable (or set of indicator variables) was added separately to a model including age and race a priori. Variables that changed the effect estimates of exposure of interest by 10% or more were considered to be confounders of the relation between traffic or air pollution and uterine leiomyomata risk, and were included in “parsimonious” models.28 To examine the impact of all potential confounders, we also present models adjusted for all considered factors.

Statistical Analysis

As noted above, exposure information was updated every 2 years, therefore prospective time-varying Cox proportional hazards models were used to assess the relationship of uterine leiomyomata with distance to road or PM. We used cubic splines to test for the linearity of all continuous exposures. Person-months of follow-up time were calculated from July 1, 1993 until censoring. Censoring occurred at first onset of: menopause, diagnosis of infertility, hysterectomy, or cancer, date of death, loss to follow-up, or the end of follow-up (June 30, 2009). All models were based on a biennial time scale and were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). To tightly control for age and calendar year, we estimated separate baseline hazards for age in months and calendar year in the Cox models. Statistical analyses were performed in SAS version 9.2 (SAS Institute, Cary, NC). In sensitivity analyses to examine associations with more severe cases of uterine leiomyomata, we ran models restricted to those cases of uterine leiomyomata confirmed by hysterectomy only. To determine if there was effect modification by age, we performed models stratified by age (dichotomized at age 35) and created multiplicative interaction terms to assess statistical significance of differences in age-strata specific HRs and 95%CIs. We used a p<0.05 to assess statistical significance of our effects.

RESULTS

A total of 85,251 women comprised the study population for analyses of residential proximity to road, PM10, PM10–2.5, and PM2.5 and risk of uterine leiomyomata. Selected characteristics of the population over the full period of follow-up are presented in Table 1 for the full cohort and by distance to road category. The mean (standard deviation) age during follow-up was 42.6 (5.3) years, the cohort was mostly parous, and over two-thirds were never smokers. There was little difference in covariates (age, BMI, income, race, age at menarche) between the distance to road categories, with the exception of a trend toward lower parity among women living closer to a major roadway and women in the Northeast living closer to roadways then women in other regions. The mean and median levels of each of the time windows were similar within each pollutant, and there were wide ranges for all pollutants (Table 2).

Table 1.

Selected Age-standardized Characteristics of the Nurses’ Health Study II Participants with Exposure Data (N= 85,251) Over the Period of Follow-Up (1993–2007)

Entire
Cohort
By Distance (m) to Nearest A1-A3
Roadwayb

200+ m 51–199 m 0–50 m
Mean (SD)
Age (in years)a 42.6 (5.3) 42.7 (5.3) 42.5 (5.4) 42.5 (5.4)
Body Mass Index (kg/m*m) 26.0 (6.0) 25.8 (5.9) 26.0 (6.1) 26.5 (6.4)
Physical Activity (MET-hrs/week) 18.4 (25.8) 18.2 (25.4) 18.6 (26.0) 18.8 (27.4)
Alternative Healthy Eating Index 52.8 (9.8) 52.6 (9.8) 53.1 (9.8) 52.7 (9.9)
Census tract median income ($10,000) 6.69 (2.38) 6.76 (2.29) 6.69 (2.47) 6.33 (2.56)
Census tract median home value ($100,000) 1.72 (1.23) 1.66 (1.07) 1.84 (1.39) 1.75 (1.56)
Percent of Person-Time
Caucasian race 94 95 93 93
Age at Menarche (years)
  Less than 12 23 22 23 23
  12 30 30 30 30
  Greater than 12 47 47 47 46
Parity
  Nulliparous 19 15 20 24
  Parous 81 84 79 75
Oral Contraception Use
  Never 14 13 15 15
  Past 75 75 73 74
  Current 10 10 10 10
Cigarette Smoking
  Never 68 69 66 66
  Current 9 8 9 10
  Former 24 23 24 24
Individual Level SES
  Married 64 66 61 59
  Live Alone 7 6 9 11
  Household Income ($)
    >15,000 0 0 0 0
    15,000–19,999 1 0 0 0
    20,000–29,999 3 1 1 1
    30,000–39,999 6 2 3 4
    40,000–49,999 18 6 6 7
    50,000–74,999 15 18 19 21
    75,000–99,999 16 15 15 14
    100,000–149,999 9 17 16 14
    ≥150,000 0 10 9 8
Region of Residence
  Northeast 34 32 36 41
  Midwest 34 36 31 31
  West 15 13 20 14
  South 17 19 13 13
a

Value is not age adjusted

b

Each cohort member may be in multiple distance categories over follow-up

NOTE: Values are standardized to the age distribution of the study population.

Table 2.

Distributions of the Particulate Matter Pollution Metrics (µg/m3) Among 85,251 Women in the Nurses’ Health Study II over the Full Period of Follow-Up (1993–2007).

Metric Mean (SD) Median (IQR) Min Max
24-month average
    PM10 22.6 (6.2) 21.8 (7.0) 3.7 72.3
    PM10–25 9.0 (4.6) 8.0 (5.2) −0.2 54.0
    PM2.5 13.7 (3.0) 13.6 (4.1) 2.0 28.2
48-month average
    PM10 21.3 (5.5) 20.7 (6.2) 4.0 60.1
    PM10–25 8.3 (4.2) 7.3 (4.9) 0.1 46.0
    PM2.5 13.1 (2.7) 13.0 (3.7) 2.2 23.9
Cumulative average
    PM10 25.8 (6.4) 25.0 (6.8) 5.1 80.6
    PM10–25 10.6 (4.8) 9.6 (5.3) 1.5 60.7
    PM2.5 15.2 (3.1) 15.3 (4.2) 2.7 29.3

Among 837,573 person-years of follow-up, there were a total of 7,760 incident cases of surgically or ultrasonographically confirmed uterine leiomyomata. In models only adjusted for age and calendar time, living closer to a roadway was associated with small, but generally not statistically significant, elevations in the risk of uterine leiomyomata, compared to living further from a roadway (Table 3). BMI, parity, age at first birth, age at last birth, total months of exclusive breastfeeding, and months since last birth individual- and area-level socioeconomic status, antihypertensive drugs and diastolic blood pressure, and region of the country met our definition of confounders and were included in our parsimoniously adjusted models. There was little difference in the results from the parsimoniously and multivariable adjusted models, and in the full cohort no associations were observed between uterine leiomyomata and distance to road.. However, although there was no statistically significant evidence of effect modification by age, among younger women (≤35 years of age), women living closest (0–50m) to a roadway did have elevated, but nonstatistically significant risks of uterine leiomyomata compared to women living 200m or more away. This elevation was not observed among women over age 35.

Table 3.

Basic and Fully Adjusted Hazard Ratios and 95% Confidence Intervals (CIs) of Uterine Leiomyoma Risk (1993–2007) by Residential Proximity to Roadway, Among 85,251 Women in the Nurses’ Health Study II

All Women ≤35 Years
old
>35 Years
old
Exposure Person-
years
Cases Basic
HR
95% CIa
Parsimonious
Adjusted HR
95% CIb
Multivariable
Adjusted HR
95% CIc
Multivariable
Adjusted HR
95% CIc
Multivariable
Adjusted HR
95% CIc
Distance to A1-A3 Roads (m)
0–50 97,011 925 1.05
(0.98–1.12)
1.02
(0.95–1.09)
1.01
(0.93–1.09)
1.15
(0.85–1.56)
1.01
(0.94–1.09)
51–199 213,961 2,043 1.05
(1.00–1.11)
1.05
(1.00–1.11)
1.04
(0.98–1.11)
0.98
(0.76–1.25)
1.06
(1.00–1.12)
200+ 526,601 4,792 reference reference reference reference reference
Distance to A1-A2 Roads (m)
0–50 10,406 103 1.07
(0.88–1.30)
1.01
(0.83–1.23)
1.00
(0.80–1.25)
1.34
(0.65–2.74)
1.00
(0.81–1.22)
51–199 42,862 404 1.02
(0.92–1.13)
1.02
(0.92–1.12)
1.02
(0.91–1.15)
0.70
(0.62–1.51)
1.02
(0.92–1.13)
200+ 784,305 7,253 reference reference reference reference reference
a

Adjusted for age and calendar time

b

Adjusted for age, calendar time, race, and covariates that consistently changed the effect estimates at least 10% in univariate models (current body mass index, parity, age at first and last birth, time since last birth, total months of exclusive breastfeeding, antihypertensive medication use and blood pressure, region of the country, individual level SES (marital status, household income, live with others or alone), and Census tract level median income and median home value)

c

Adjusted for age, calendar time, race, current body mass index, smoking status, overall diet quality, physical activity, infertility, parity, oral contraceptive use, age at menarche, age at first and last birth, time since last birth, total months of exclusive breastfeeding, antihypertensive medication use and blood pressure, region of the country, individual level SES (marital status, household income, live with others or alone), and Census tract level median income and median home value

NOTE: A total of 360 cases were diagnosed in women ≤35 Years old, and 7,400 were diagnosed in women over 35.

There was no statistically significant evidence of deviations from linearity for any of our continuous measures of PM, therefore, we present the results in terms of a 10 µg/m3 increase. And again, there was little difference between the parsimoniously and multivariable adjusted models. There was no association observed between increasing exposure to PM10 or PM10–2.5 and risk of uterine leiomyomata in any of the time windows examined in the full cohort (Table 4). However, each 10 µg/m3 increase in 2-year average, 4-year average, and time-varying cumulative average exposure to PM2.5 was associated with a hazard ratio of 1.08 (95%CI: 1.00, 1.17), 1.09 (95%CI: 0.99, 1.19) and 1.11 (95%CI: 1.03, 1.19), respectively. In models stratified by age, these results were stronger among the younger women, although again there was no statistically significant evidence of effect modification.

Table 4.

Basic and Fully Adjusted Hazard Ratios and 95% Confidence Intervals (CIs) of Uterine Leiomyoma Risk (1993–2007) for Each 10 µg/m3 Increase in Particulate Matter, Among 85,251 Women in the Nurses’ Health Study II

All Women ≤35 Years old >35 Years old

Exposure Basic HR
95% CI a
Parsimonious
Adjusted HR
95% C b
Multivariable
Adjusted HR
95% CI b
Multivariable
Adjusted HR
95% CI c
Multivariable
Adjusted HR
95% CI c
24 month Average Exposure
    PM10 1.02
(0.98–1.06)
1.04
(0.99–1.09)
1.04
(0.99–1.09)
1.16
(0.95–1.41)
1.03
(0.99–1.08)
    PM10–2.5 0.98
(0.95–1.05)
1.03
(0.96–1.10)
1.03
(0.97–1.10)
1.27
(0.95–1.71)
1.02
(0.96–1.09)
    PM2.5 1.07
(0.99–1.15)
1.08
(1.00–1.17)
1.08
(1.00–1.17)
1.12
(0.79–1.61)
1.08
(0.99–1.17)
48 month Average Exposure
    PM10 1.02
(0.98–1.06)
1.04
(0.99–1.09)
1.04
(1.00–1.09)
1.17
(0.93–1.48)
1.03
(0.98–1.07)
    PM10–2.5 1.00
(0.94–1.05)
1.02
(0.95–1.10)
1.02
(0.96–1.10)
1.89
(0.85–1.66)
1.02
(0.95–1.09)
    PM2.5 1.08
(0.99–1.18)
1.09
(1.00–1.19)
1.09
(0.99–1.19)
1.28
(0.86–1.92)
1.08
(0.99–1.18)
Cumulative Average Exposure
    PM10 1.01
(0.97–1.04)
1.04
(1.00–1.08)
1.04
(1.00–1.08)
1.21
(1.00–1.45)
1.03
(0.99–1.08)
    PM10–2.5 0.98
(0.93–1.03)
1.01
(0.95–1.08)
1.01
(0.95–1.06)
1.30
(0.99–1.69)
1.00
(0.94–1.07)
    PM2.5 1.08
(1.00–1.17)
1.11
(1.03–1.20)
1.11
(1.03–1.19)
1.23
(0.88–1.73)
1.11
(1.02–1.19)
a

Adjusted for age and calendar time

b

Adjusted for age, calendar time, race, and covariates that consistently changed the effect estimates at least 10% in univariate models (current body mass index, parity, age at first and last birth, time since last birth, total months of exclusive breastfeeding, antihypertensive medication use and blood pressure, region of the country, individual level SES (marital status, household income, live with others or alone), and Census tract level median income and median home value)

c

Adjusted for age, calendar time, race, current body mass index, smoking status, overall diet quality, physical activity, infertility, parity, oral contraceptive use, age at menarche, age at first and last birth, time since last birth, total months of exclusive breastfeeding, antihypertensive medication use and blood pressure, region of the country, individual level SES (marital status, household income, live with others or alone), and Census tract level median income and median home value

NOTE: A total of 360 cases were diagnosed in women ≤35 Years old, and 7,400 were diagnosed in women over 35.

In analyses restricted to cases diagnosed by hysterectomy only (2,183 cases), there was little evidence of relationships between uterine leiomyomata risk and distance to road, or any of the measures of PM (results not shown).

DISCUSSION

In this study, we did not observe a relationship between distance to road or larger size fractions (PM10, PM10–2.5) of particulate matter or residential distance to road and the risk of uterine leiomyomata overall. However, a suggestive association was seen between exposure to the smallest sized fraction, PM2.5, and increased uterine leiomyomata risk that was consistent across all of the examined time windows of exposure. There was also a suggestion of higher and more consistent risks among women 35 years of age or younger, although there was no statistically significant evidence of effect modification by age. To the best of our knowledge, this is the first epidemiologic study to assess the association between degree of exposure to air pollution and uterine leiomyomata.

To the best of our knowledge, no other study has examined the impact of air pollution exposures on the risk of uterine leiomyomata. However, a handful of studies have examined the impact of cigarette smoking, a much higher exposure to particles, on uterine leiomyomata incidence. A case-control study performed in Italy demonstrated a protective effect of tobacco smoking on odds of uterine leiomyomata.29 A study of risk factors for surgically removed uterine leiomyomata in the California Teachers Study, a prospective cohort study, demonstrated a protective effect in smokers.30 The Black Women’s Health Study and Nurses’ Health Study, two large prospective studies evaluating first-hand tobacco smoking and risk of uterine leiomyomata, reported null associations between tobacco smoke exposure and risk of uterine leiomyomata.31,32 The Uterine Fibroid Study evaluated risk factors with different sub-types of uterine leiomyomata categorized by tumor location (submucosal, intramural, subserosal, and diffuse disease); this study demonstrated increased risk of diffuse uterine leiomyomatosis in tobacco smokers.33 However comparisons between air pollution exposures and tobacco exposures must be undertaken cautiously as studies have suggested that tobacco smoke has an anti-estrogenic effect,34,35 where limited in vitro studies have suggest estrogenic effects of air pollution.16

This study has limitations to consider. We used ambient exposures as a proxy for personal exposures, likely leading to exposure misclassification. For example, we have no information on the proportion each day the woman spent at home or on the characteristics of the home (e.g., age, ventilation rate, air purification systems, etc.) that may affect the experienced levels of ambient PM or traffic pollution. However, studies suggest that ambient measurements are an acceptable surrogate 3638 for personal exposures in most populations. In addition, this approach is useful because regulation typically focuses on ambient levels.39 Another limitation is that the NHSII cohort is not representative of the general US population in terms of socio-economic status (SES) and race. The NHSII cohort is predominantly Caucasian (although the racial distribution is representative of US licensed nurses at baseline) with residence in neighborhoods of medium to high SES. Hence, we were unable to evaluate effect modification by race. Finally, our strict definition of UL allowed us to identify clinically symptomatic uterine leiomyomata. However we were unable to assess the impact of air pollution exposure on the development of non-clinically evident uterine leiomyomata disease. As with any study, although we adjusted for a large number of well-characterized time-varying potential confounders, there is always the possibility that residual or unmeasured confounding may explain our small elevations in risk.

This large study has several notable strengths. For this analysis, we had 14 years of detailed residential address history and only included residential addresses with a street segment level geocoding match. The use of only street segment level matches likely reduced exposure misclassification compared to matches to a zip-code centroid or other administrative boundaries (Census tract, county, etc). Prospective information on several covariates was collected biennially allowing for time-varying control of confounding variables. Self-report of uterine leiomyomata had been previously validated with excellent concordance between medical record and self-report. The use of individual residential specific monthly pollution exposures is state of the art and allows us to examine various time windows of exposure. The geographic distribution represented by the participants of this study provides information on most environments throughout the continental US.

This study identified a modest association between chronic fine PM exposure and incidence of uterine leiomyomata and distance from road and uterine leiomyomata incidence among women age 35 and under. Repeat studies are needed to confirm these associations. Furthermore, studies looking at the association between air pollution and fibroids may be warranted in countries with much higher levels of air pollution.

Acknowledgments

The authors would like to thank the participants of the Nurses’ Health Study II for their continued enthusiastic participation.

Supported by grant 5K12HD043444-10 and R01HD57210 from the National Institute of Child Health and Human Development, R01CA50385 from the National Cancer Institute, 5R01ES017017 from the National Institute for Environmental Health Sciences, an infrastructure grant from the National Cancer Institute: UM1CA176726, a research grant from the Boston University Department of Obstetrics and Gynecology, and the Massachusetts Institute of Technology Center for Environmental Health Sciences Translational Pilot Project Program.

Abbreviations

BMI

Body Mass Index

CI

Confidence Interval

GIS

Geographic Information Systems

HR

Hazard Ratio

PM

Particulate Matter

NHSII

Nurses’ Health Study II

PM10

Course Particulate Matter, 10 micron diameter

PM2.5

Fine Particulate Matter, 2.5 micron diameter

SES

Socio-economic Status

Footnotes

Competing Financial Interests: The authors have no actual or potential competing financial interests to disclose.

References

  • 1.Catherino WH, Parrott E, Segars J. Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop. Fertility and sterility. 2011;95(1):9–12. doi: 10.1016/j.fertnstert.2010.08.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hildreth Cj LCGRM. UTerine fibroids. JAMA: The Journal of the American Medical Association. 2009;301(1):122–122. doi: 10.1001/jama.301.1.122. [DOI] [PubMed] [Google Scholar]
  • 3.Stewart EA. Uterine fibroids. The Lancet. 2001;357(9252):293–298. doi: 10.1016/S0140-6736(00)03622-9. [DOI] [PubMed] [Google Scholar]
  • 4.Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. American journal of obstetrics and gynecology. 2003;188(1):100–107. doi: 10.1067/mob.2003.99. [DOI] [PubMed] [Google Scholar]
  • 5.Buttram VC, Jr., Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertility and sterility. 1981;36(4):433–445. doi: 10.1016/s0015-0282(16)45789-4. [DOI] [PubMed] [Google Scholar]
  • 6.Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005;105(3):563–568. doi: 10.1097/01.AOG.0000154161.03418.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environmental health perspectives. 2003;111(8):1037–1054. doi: 10.1289/ehp.5787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Baird DD, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol. 2005;20(1):81–84. doi: 10.1016/j.reprotox.2005.01.002. [DOI] [PubMed] [Google Scholar]
  • 9.Mahalingaiah S, Hart JE, Wise LA, Terry KL, Boynton-Jarrett R, Missmer SA. Prenatal Diethylstilbestrol Exposure and Risk of Uterine Leiomyomata in the Nurses' Health Study II. American journal of epidemiology. 2013 doi: 10.1093/aje/kwt250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shen Y, Xu Q, Ren M, Feng X, Cai Y, Gao Y. Measurement of phenolic environmental estrogens in women with uterine leiomyoma. PloS one. 2013;8(11):e79838. doi: 10.1371/journal.pone.0079838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Eskenazi B, Warner M, Samuels S, Young J, Gerthoux PM, Needham L, Patterson D, Olive D, Gavoni N, Vercellini P, Mocarelli P. Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women's Health Study. American journal of epidemiology. 2007;166(1):79–87. doi: 10.1093/aje/kwm048. [DOI] [PubMed] [Google Scholar]
  • 12.Lambertino A, Turyk M, Anderson H, Freels S, Persky V. Uterine leiomyomata in a cohort of Great Lakes sport fish consumers. Environmental research. 2011;111(4):565–572. doi: 10.1016/j.envres.2011.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bidgoli SA, Khorasani H, Keihan H, Sadeghipour A, Mehdizadeh A. Role of endocrine disrupting chemicals in the occurrence of benign uterine leiomyomata: special emphasis on AhR tissue levels. Asian Pacific journal of cancer prevention : APJCP. 2012;13(11):5445–5450. doi: 10.7314/apjcp.2012.13.11.5445. [DOI] [PubMed] [Google Scholar]
  • 14.Lioy PJ, Greenberg A. Factors associated with human exposures to polycyclic aromatic hydrocarbons. Toxicology and industrial health. 1990;6(2):209–223. [PubMed] [Google Scholar]
  • 15.Misaki K, Suzuki M, Nakamura M, Handa H, Iida M, Kato T, Matsui S, Matsuda T. Aryl hydrocarbon receptor and estrogen receptor ligand activity of organic extracts from road dust and diesel exhaust particulates. Arch Environ Contam Toxicol. 2008;55(2):199–209. doi: 10.1007/s00244-007-9110-5. [DOI] [PubMed] [Google Scholar]
  • 16.Oh SM, Ryu BT, Chung KH. Identification of estrogenic and antiestrogenic activities of respirable diesel exhaust particles by bioassay-directed fractionation. Arch Pharm Res. 2008;31(1):75–82. doi: 10.1007/s12272-008-1123-8. [DOI] [PubMed] [Google Scholar]
  • 17.Sidlova T, Novak J, Janosek J, Andel P, Giesy JP, Hilscherova K. Dioxin-like and endocrine disruptive activity of traffic-contaminated soil samples. Arch Environ Contam Toxicol. 2009;57(4):639–650. doi: 10.1007/s00244-009-9345-4. [DOI] [PubMed] [Google Scholar]
  • 18.Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90(6):967–973. doi: 10.1016/s0029-7844(97)00534-6. [DOI] [PubMed] [Google Scholar]
  • 19.Lipfert FW, Wyzga RE. On exposure and response relationships for health effects associated with exposure to vehicular traffic. J Expo Sci Environ Epidemiol. 2008;18(6):588–599. doi: 10.1038/jes.2008.4. [DOI] [PubMed] [Google Scholar]
  • 20.Adar SD, Kaufman JD. Cardiovascular disease and air pollutants: evaluating and improving epidemiological data implicating traffic exposure. Inhal Toxicol. 2007;19(Suppl 1):135–149. doi: 10.1080/08958370701496012. [DOI] [PubMed] [Google Scholar]
  • 21.Lipfert FW, Baty JD, Miller JP, Wyzga RE. PM2.5 constituents and related air quality variables as predictors of survival in a cohort of U.S. military veterans. Inhal Toxicol. 2006;18(9):645–657. doi: 10.1080/08958370600742946. [DOI] [PubMed] [Google Scholar]
  • 22.Sahlodin AM, Sotudeh-Gharebagh R, Zhu Y. Modeling of dispersion near roadways based on the vehicle-induced turbulence concept. Atmospheric Environment. 2007;41(1):92–102. [Google Scholar]
  • 23.Zhu Y, Hinds WC, Kim S, Sioutas C. Concentration and size distribution of ultrafine particles near a major highway. J Air Waste Manag Assoc. 2002;52(9):1032–1042. doi: 10.1080/10473289.2002.10470842. [DOI] [PubMed] [Google Scholar]
  • 24.Yanosky JD, Paciorek C, Schwartz J, Laden F, Puett R, Suh H. Spatio-temporal modeling of chronic PM10 exposure for the Nurses' Health Study. Atmospheric Environment. 2008;42(18):4047–4062. doi: 10.1016/j.atmosenv.2008.01.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yanosky JD, Paciorek CJ, Suh HH. Predicting chronic fine and coarse particulate exposures using spatiotemporal models for the Northeastern and Midwestern United States. Environ Health Perspect. 2009;117(4):522–529. doi: 10.1289/ehp.11692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yanosky JD, Schwartz J, Suh HH. Associations between measures of socioeconomic position and chronic nitrogen dioxide exposure in Worcester, Massachusetts. J Toxicol Environ Health A. 2008;71(24):1593–1602. doi: 10.1080/15287390802414307. [DOI] [PubMed] [Google Scholar]
  • 27.Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, Stampfer MJ, Willett WC. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142(6):1009–1018. doi: 10.3945/jn.111.157222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Greenland S. Modeling and variable selection in epidemiologic analysis. American journal of public health. 1989;79(3):340–349. doi: 10.2105/ajph.79.3.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Parazzini F, Negri E, La Vecchia C, Rabaiotti M, Luchini L, Villa A, Fedele L. Uterine myomas and smoking. Results from an Italian study. The Journal of reproductive medicine. 1996;41(5):316–320. [PubMed] [Google Scholar]
  • 30.Templeman C, Marshall SF, Clarke CA, Henderson KD, Largent J, Neuhausen S, Reynolds P, Ursin G, Bernstein L. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertility and sterility. 2009;92(4):1436–1446. doi: 10.1016/j.fertnstert.2008.08.074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, Rosenberg L. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study. Human reproduction. 2004;19(8):1746–1754. doi: 10.1093/humrep/deh309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Marshall LM, Spiegelman D, Manson JE, Goldman MB, Barbieri RL, Stampfer MJ, Willett WC, Hunter DJ. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology. 1998;9(5):511–517. [PubMed] [Google Scholar]
  • 33.Dragomir AD, Schroeder JC, Connolly A, Kupper LL, Hill MC, Olshan AF, Baird DD. Potential risk factors associated with subtypes of uterine leiomyomata. Reproductive sciences. 2010;17(11):1029–1035. doi: 10.1177/1933719110376979. [DOI] [PubMed] [Google Scholar]
  • 34.Daniel M, Martin AD, Faiman C. Sex hormones and adipose tissue distribution in premenopausal cigarette smokers. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 1992;16(4):245–254. [PubMed] [Google Scholar]
  • 35.MacMahon B, Trichopoulos D, Cole P, Brown J. Cigarette smoking and urinary estrogens. The New England journal of medicine. 1982;307(17):1062–1065. doi: 10.1056/NEJM198210213071707. [DOI] [PubMed] [Google Scholar]
  • 36.Janssen NA, de Hartog JJ, Hoek G, Brunekreef B, Lanki T, Timonen KL, Pekkanen J. Personal exposure to fine particulate matter in elderly subjects: relation between personal, indoor, and outdoor concentrations. J Air Waste Manag Assoc. 2000;50(7):1133–1143. doi: 10.1080/10473289.2000.10464159. [DOI] [PubMed] [Google Scholar]
  • 37.Janssen NA, Hoek G, Brunekreef B, Harssema H, Mensink I, Zuidhof A. Personal sampling of particles in adults: relation among personal, indoor, and outdoor air concentrations. Am J Epidemiol. 1998;147(6):537–547. doi: 10.1093/oxfordjournals.aje.a009485. [DOI] [PubMed] [Google Scholar]
  • 38.Sarnat JA, Schwartz J, Catalano PJ, Suh HH. Gaseous pollutants in particulate matter epidemiology: confounders or surrogates? Environ Health Perspect. 2001;109(10):1053–1061. doi: 10.1289/ehp.011091053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Pope CA, Dockery DW. Epidemiology of particle effects. In: Holgate ST, Samet JM, Koren HS, Maynard RL, editors. Air pollution and health. Boston: Academic Press; 1999. [Google Scholar]

RESOURCES